SeekingAlpha · Feb 18, 2026
NYSE · USNA
USANA Health Sciences Inc
Consumer Defensive · Packaged Foods
$15.12
Down-$0.29 (-1.92%)
Updated Sep 11, 2026, 12:41 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 374.67M
- P/E ratio
- 22.03
- Dividend yield
- 0.00%
- 52-week range
- $12.57 – $31.15
- Volume
- 254.36K
- Avg. volume
- 249.37K
Price performance
USNA price history
1M range · 0 trading sessions · Daily adjusted prices
USNA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest USNA news
The latest Smart Investors Daily articles mentioning USNA.
Stock researchCompany · Overview
USNA research
Overview
Company profile and research snapshot.
Company profile
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $35.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 27, 2025 | DA Davidson | Neutral | — |
| Jan 2, 2025 | DA Davidson | Neutral | — |
| Oct 23, 2024 | DA Davidson | Neutral | — |
| Jul 25, 2024 | DA Davidson | Neutral | — |
| May 7, 2024 | DA Davidson | Neutral | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 18, 2026
USANA Health Sciences shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 adjusted EPS guidance above estimates.
ChartMill · Feb 17, 2026
USANA Health Sciences Inc (NYSE:USNA) Reports Mixed Q4 Results with Strong EPS Beat and Positive 2026 Outlook
USANA reports mixed Q4 results with earnings beat and strong 2026 guidance, highlighting strategic shift to omnichannel brands like Hiya and Rise Wellness.
Benzinga · Feb 17, 2026
Usana Health Sciences Q4 Earnings Assessment
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
